The outcome of colon adenocarcinoma (COAD) patients remains dismal. and lactate metabolism has been characterized to promote tumor development and immune evasion. Based on the above background. it is worthwhile to explore novel prognostic and therapeutic biomarkers for COAD patients from the aspect of lactate metabolism. https://yeswellneses.shop/product-category/digestive-enzymes/